Taurus Mutual FundEquity Scheme - ELSS13.8 years
The scheme seeks long term capital appreciation. The scheme would take around 80-85 per cent exposure to equity, while exposure to bonds and money market instruments would be up to 20 per cent of the corpus. The scheme was made open-ended in February 2001.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Maximum drawdown exceeded 35%.
Prefer peers if · Prefer Baroda BNP Paribas ELSS Tax Saver Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
2.06% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -35.0%. Ask whether you can hold through a similar fall.
Vs category
Watch
40% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Anuj Kapil · 3.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / lock-in
Watch
ELSS locks each installment for 3 years. Useful only if 80C is open on the old regime - otherwise locked equity.
Portfolio concentration
Watch
Top 10 holdings ≈ 58.4% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 35%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
ELSS lock-in
Every installment locks for 3 years. Only useful if 80C is still open on the old regime - otherwise it is locked equity, not a tax cut.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
19 Feb 2020 – 6 Nov 2020
Trough 23 Mar 2020 · recovered in 228 days
-35.0%
7 Aug 2015 – 20 Jul 2016
Trough 25 Feb 2016 · recovered in 146 days
-21.4%
21 Jan 2013 – 24 Mar 2014
Trough 28 Aug 2013 · recovered in 208 days
-21.0%
29 Oct 2025 – open
Trough 31 Mar 2026 · not recovered
-16.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
56
Vs category
55
Consistency
39
Risk-adjusted
48
Drawdown
12
Mean
42
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 33 holdings · top 10 are 58.4%.
Divi's Laboratories Ltd
Healthcare
8.2%
Bajaj Holdings & Investment Ltd
Financial
6.9%
HDFC Bank Ltd
Financial
6.9%
ICICI Bank Ltd
Financial
6.8%
Megasoft Ltd
Technology
6.2%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Baroda BNP Paribas Mutual Fund
Aditya Birla Sun Life Mutual Fund
Caveat: Deeper drawdown
Kotak Mahindra Mutual Fund
Caveat: Deeper drawdown
PPFAS Mutual Fund
Caveat: Lower trailing returns
SBI Mutual Fund
Caveat: Deeper drawdown
Taurus Mutual FundEquity Scheme - ELSS13.8 years
The scheme seeks long term capital appreciation. The scheme would take around 80-85 per cent exposure to equity, while exposure to bonds and money market instruments would be up to 20 per cent of the corpus. The scheme was made open-ended in February 2001.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Maximum drawdown exceeded 35%.
Prefer peers if · Prefer Baroda BNP Paribas ELSS Tax Saver Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
2.06% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -35.0%. Ask whether you can hold through a similar fall.
Vs category
Watch
40% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Anuj Kapil · 3.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / lock-in
Watch
ELSS locks each installment for 3 years. Useful only if 80C is open on the old regime - otherwise locked equity.
Portfolio concentration
Watch
Top 10 holdings ≈ 58.4% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 35%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
ELSS lock-in
Every installment locks for 3 years. Only useful if 80C is still open on the old regime - otherwise it is locked equity, not a tax cut.
NAV
30 Oct 2026 · -6.8% over 1Y
193.28
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-7.4%
19 Feb 2020 – 6 Nov 2020
Trough 23 Mar 2020 · recovered in 228 days
-35.0%
7 Aug 2015 – 20 Jul 2016
Trough 25 Feb 2016 · recovered in 146 days
-21.4%
21 Jan 2013 – 24 Mar 2014
Trough 28 Aug 2013 · recovered in 208 days
-21.0%
29 Oct 2025 – open
Trough 31 Mar 2026 · not recovered
-16.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
56
Vs category
55
Consistency
39
Risk-adjusted
48
Drawdown
12
Mean
42
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 33 holdings · top 10 are 58.4%.
Divi's Laboratories Ltd
Healthcare
8.2%
Bajaj Holdings & Investment Ltd
Financial
6.9%
HDFC Bank Ltd
Financial
6.9%
ICICI Bank Ltd
Financial
6.8%
Megasoft Ltd
Technology
6.2%